Department of Otolaryngology Head and Neck Surgery, Head and Neck Disease Diagnosis and Treatment Center, Kunming Childrens Hospital, Kunming 650228, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology Head and Neck Surgery, Head and Neck Disease Diagnosis and Treatment Center, Kunming Childrens Hospital, Kunming 650228, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology Head and Neck Surgery, Head and Neck Disease Diagnosis and Treatment Center, Kunming Childrens Hospital, Kunming 650228, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology Head and Neck Surgery, Head and Neck Disease Diagnosis and Treatment Center, Kunming Childrens Hospital, Kunming 650228, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology Head and Neck Surgery, Head and Neck Disease Diagnosis and Treatment Center, Kunming Childrens Hospital, Kunming 650228, China 在知网中查找 在百度中查找 在本站中查找
Department of Otolaryngology Head and Neck Surgery, Head and Neck Disease Diagnosis and Treatment Center, Kunming Childrens Hospital, Kunming 650228, China 在知网中查找 在百度中查找 在本站中查找
Objective To observe the effect of drug-eluting stent in the treatment of congenital choanal atresia (CCA). Methods A retrospective study was performed in 14 patients with CCA hospitalized in Kunming Children's Hospital from Jan 2016 to Dec 2019. Low-temperature plasma radiofrequency ablation was used to remove the membranous part of the atresia plate, and an osteotome was used to remove the bony part. After removal of the atresia plate, drug-eluting stent was placed in 6 patients and U-tape stent in 8. The incidence of postoperative complications was compared between the two groups. Results All the cases had been followed up more than 6 months postoperatively. No postoperative nasal adhesion occurred in the drug-eluting stent group with a granulation proliferation rate of 10%. The rates of postoperative nasal adhesion and granulation proliferation were 44.4% and 55.6% in the U-tape stent group. The differences between the two groups were statistically significant (both P<0.05). The rate of nostril reocclusion in the drug-eluting stent group (10%) was lower than that of the U-tape stent group (33.3%), but the difference was statistically insignificant (P>0.05). Conclusion The drug-eluting stent can be used as a novel type of stent in the treatment of CCA.